ASCO Immunotherapy Alert: BioMedTracker’s Top Abstract Picks
Executive Summary
With cancer checkpoint inhibitors extremely high on the radar at the upcoming American Society of Clinical Oncology annual meeting, BioMedTracker analysts identify the most compelling immunotherapy abstracts.